Sale
(Box) Status™ COVID-19/Flu A&B Combo Rapid Test Kit CLIA Waived, 25/Bx
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens
Promo offer for this product
Features and benefits
COVID-19
– Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
– Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
Flu A – Sensitivity 91.4%, Specificity 95.7%
Flu B – Sensitivity 87.6%, Specificity 95.9%
FDA Emergency Use Authorization (EUA)
Visually read in 15 minutes
Flocked nasopharyngeal swab for superior specimen collection and patient comfort
Additional information
| Brand |
Status |
|---|---|
| Item |
Antigen |
| CLIA |
CLIA Waived |
| Registration |
EUA FDA |
| Category? |
Infectious Disease |
| Certifications |
ISO 13485 |
Packaging and Shipping
Packaging details:
- Minimum order quantity: One Box
- Packaging Details: 25 Kit/ Box, 20 Boxes/ Case
- Weight: 1.1 lbs
- Dimensions: 10'' x 6'' x 4''
Shipping details:
- Shipped from US Michigan.
- Ships Same day if ordered before 12.00 p.m EST or next Business day.
- Return is not accepted if the case or bag is opened, or the seal is broken.
Instruction of use
SellSheet_80645_Lifesign_Status Flu Covid.11.3.21
P-52730-E Status Flu 2019 2020 2021 Annual Reactivity Testing Results appendix_0
03 - EUA210015.S007.Princeton.Biomed.HCP Fact Sheet.05-12-2023
04 - EUA210015.S007.Princeton.Biomed.PATIENT Fact Sheet.05-12-2023
05 - EUA210015.S007.P-5383-E Status COVID-19 Flu QRI procedure card.05-12-2023
06 - EUA210015.S007.Status COVID-19 Flu package insert IFU.05-12-2023